AMERISAFE, Inc. logo AMSF - AMERISAFE, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $44.50 DETAILS
HIGH: $55.00
LOW: $34.00
MEDIAN: $44.50
CONSENSUS: $44.50
UPSIDE: 43.32%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 46.0% below fair value
Current Price $31.05
Bear Case $46.67 50.3% upside ($46.67 - $31.05) / $31.05 = 50.3% ROTCE 15.3% → 4.00x TBV
Fair Value $57.46 85.1% upside ($57.46 - $31.05) / $31.05 = 85.1% ROTCE 20.5% → 4.00x TBV
Bull Case $74.69 140.5% upside ($74.69 - $31.05) / $31.05 = 140.5% ROTCE 23.5% → 4.00x TBV

Adjust Assumptions

20.5%
6.0%

Key Value Driver

ROTCE (20.5%) vs. cost of equity (6.0%)

Implied Market Multiple 2.52x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $44.50 from 6 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $57.46 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $44.50 (from 6 analysts). Our estimate is 36% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly